JIPS Pharmaceuticals

Sahibzada Ajit Singh Nagar, India Founded: 2017 • Age: 9 yrs
Manufactures and supplies a range of pharmaceutical formulations and tablets.

About JIPS Pharmaceuticals

JIPS Pharmaceuticals is a Healthcare company based in Sahibzada Ajit Singh Nagar (India) founded in 2017. It manufactures and supplies a range of pharmaceutical formulations and tablets. It operates on a B2B model. The company has 16 employees. Its Indian entity Jips Pharmaceuticals Private Limited reported revenue of β‚Ή27.63 Cr. Its focus areas include Pharmaceuticals, Drug Manufacturing and Formulations and Tablets. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.

Company details

JIPS Pharmaceuticals manufactures and supplies a range of pharmaceutical formulations and tablets through providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and formulations and tablets. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Key Metrics
  • Annual Revenue
    ₹27.63 Cr

    FY 2023 · +19% YoY

  • Net Profit
    ₹89.3 Lakh

    FY 2023 · 3% margin

  • EBITDA
    ₹1.44 Cr

    FY 2023 · 5% margin

  • Employee Count
    16

Board of directors of Jips Pharmaceuticals Private Limited (JIPS Pharmaceuticals)

Jips Pharmaceuticals Private Limited is the primary company behind JIPS Pharmaceuticals. The board of Jips Pharmaceuticals Private Limited currently have 4 directors; the longest-serving is Jagdeep Singh, appointed in 2017.

DirectorDesignationAppointedTenureEntity
Jagdeep Singh
DIN 07672365
Director13 Jan 20179 yrs 9 moJips Pharmaceuticals Private Limited
Parvinder Jit Singh
DIN 07673268
Director13 Jan 20179 yrs 9 moJips Pharmaceuticals Private Limited
Irvandeep Kaur
DIN 07673286
Director17 Jan 20179 yrs 9 moJips Pharmaceuticals Private Limited
Supreet Singh
DIN 07511639
Director17 Jan 20179 yrs 9 moJips Pharmaceuticals Private Limited

Financials of JIPS Pharmaceuticals

Figures of Jips Pharmaceuticals Private Limited, the primary company behind JIPS Pharmaceuticals, for FY 2023. Revenue was ₹27.63 Cr (+19% year on year). Net profit was ₹89.3 Lakh (3% margin). EBITDA was ₹1.44 Cr (5% margin). Revenue has grown at a compounded annual rate of +29% over three years and +59% over five years.

  • ₹27.63 CrRevenue · FY 2023 · +19% YoY
  • ₹89.3 LakhNet profit · 3% margin
  • ₹1.44 CrEBITDA · 5% margin
  • ₹10 LakhPaid-up capital
  • 16Employees (provident fund records)
  • +29%Revenue CAGR, 3 years
  • +59%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Jips Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for JIPS Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to JIPS Pharmaceuticals

JIPS Pharmaceuticals has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
akums.in2004Delhi, India$70M395
CDMO focusing on spectrum of dosage forms and therapeutic segments
jubl.com1978Noida, India
Company offering a suite of R&D and manufacturing services for small molecules and generics
neclife.com1995Chandigarh, India$46.85M175
Cephalosporin APIs and generic formulations are manufactured.
Premium access

Detailed similar companies of JIPS Pharmaceuticals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about JIPS Pharmaceuticals

JIPS Pharmaceuticals was founded in 2017.

JIPS Pharmaceuticals is headquartered in Sahibzada Ajit Singh Nagar, India. It is registered at Sahibzada Ajit Singh Nagar, Punjab, India.

JIPS Pharmaceuticals has 16 employees.

The primary company behind JIPS Pharmaceuticals, Jips Pharmaceuticals Private Limited, reported revenue of β‚Ή27.63 Cr for FY 2023, up 19% year on year.

JIPS Pharmaceuticals manufactures and supplies a range of pharmaceutical formulations and tablets through providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and formulations and tablets. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

JIPS Pharmaceuticals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

JIPS Pharmaceuticals operates through Jips Pharmaceuticals Private Limited.

The legal entities of JIPS Pharmaceuticals currently have 4 directors, including Irvandeep Kaur, Supreet Singh, Jagdeep Singh and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available